Jan 30 (Reuters) - The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' (VRTX.O), opens new tab drug to treat acute pain, the health regulator said on Thursday, offering a ...

1 Day VRTX -0.71% DJIA 0.38% S&P 500 0.53% Health Care/Life Sciences 0.19% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise.

After hours: January 30 at 5:38:07 PM EST Loading Chart for BTCM ...

Readers help support Windows Report. We may get a commission if you buy through our links. Upgrading from a 32-bit to a 64-bit version of Windows can provide significant performance improvements and ...

BITS Ltd., incorporated in the year 1992, is a Mid Cap company (having a market cap of Rs 183.25 Crore) operating in Miscellaneous sector. BITS Ltd. key Products/Revenue Segments include Rent for the ...